Clinical trials
Completed Lung Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
175 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 14 |
| 2016 | 11 |
| 2017 | 22 |
| 2018 | 13 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 14 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 10 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 175 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fuda Cancer Hospital, Guangzhou | 11 |
| Peking University People's Hospital | 6 |
| Bristol-Myers Squibb | 5 |
| Ruijin Hospital | 5 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 4 |
| Jiayuan Sun | 4 |
| National Cancer Institute (NCI) | 4 |
| Shanghai Chest Hospital | 4 |
| The First Affiliated Hospital of Guangzhou Medical University | 4 |
| BeiGene | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 175 |
| Carcinoma, Non-Small-Cell Lung | 43 |
| Breast Neoplasms | 8 |
| Neoplasms | 8 |
| Adenocarcinoma of Lung | 7 |
| Carcinoma | 6 |
| Colorectal Neoplasms | 6 |
| Disease | 6 |
| Multiple Pulmonary Nodules | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 175. Each trial links to its page on Pharma Observatory.
75 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.